Randox Laboratories manufactures and distributes a range of products, including its Biochip Array Technology, for workplace drug testing (WDT) providers.
The company's Biochip Array Technology has been implemented in drug-screening programmes in countries including the UK, Italy and Vietnam.
The multiplexing Biochip Array Technology allows clinicians to detect up to 97 drug metabolites from one sample simultaneously.
The ability to carry out simultaneous tests on a biochip has led to time and labour savings in WDT, whereas traditionally only one drug could be detected at a time.
The Randox Biochip portfolio incorporates a range of illicit and prescription drugs that can be misused, putting employees at risk while they are at work.
High-risk industries that commonly employ WDT include construction, manufacturing, transport, education and security.
As well as diagnostic solutions for onsite testing and laboratory testing, Randox also provides an employee-screening service to companies.
